Growth retardation and dyslymphopoiesis accompanied by G2/M arrest in APEX2-null mice

44Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

APEX2/APE2 is a secondary mammalian apurinic/apyrimidinic endonuclease that associates with proliferating cell nuclear antigen (PCNA), and the progression of S phase of the cell cycle is accompanied by its expression. To determine the biologic significance of APEX2, we established APEX2-null mice. These mice were about 80% the size of their wild-type littermates and exhibited a moderate dyshematopoiesis and a relatively severe defect in lymphopoiesis. A significant accumulation of both thymocytes and mitogen-stimulated splenocytes in G 2/M phase was seen in APEX2-null mice compared with the wild type, indicating that APEX2 is required for proper cell cycle progression of proliferating lymphocytes. Although APEX2-null mice exhibited an attenuated immune response against ovalbumin in comparison with wild-type mice, they produced both antiovalbumin immunoglobulin M (IgM) and IgG, indicating that class switch recombination can occur even in the absence of APEX2. © 2004 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Ide, Y., Tsuchimoto, D., Tominaga, Y., Nakashima, M., Watanabe, T., Sakumi, K., … Nakabeppu, Y. (2004). Growth retardation and dyslymphopoiesis accompanied by G2/M arrest in APEX2-null mice. Blood, 104(13), 4097–4103. https://doi.org/10.1182/blood-2004-04-1476

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free